The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication
People with phenylketonuria (PKU) should note that it contains 25 mg of phenylalanine per teaspoon
El mecanismo de accin incluye varios efectos fisiolgicos importantes: estimulan la secrecin de insulina cuando los niveles de glucosa estn elevados, suprimen la liberacin de glucagn (hormona que aumenta el azcar en sangre), retrasan el vaciamiento gstrico y actan sobre centros cerebrales que regulan el apetito y la saciedad
However, it is important to note that the level of GLP-1 is diminished in people with obesity and diabetes
Personalized guidance aligns medication, nutrition, and lifestyle factors
Do not wait for routine labs Severe muscle pain, dark urine, fainting, chest pain, or severe weakness needs medical review
